Ursodeoxycholic acid or s-adenosyl methionine, phosphate restricted diets or benazepril – which are working for you, and which are wasting your clients money? This session will look at the evidence and emphasise economy and efficacy of these therapeutic options.
Key Learning Objectives:
- Be able to critically evaluate the evidence for common renal and hepatic therapies (e.g., ursodeoxycholic acid, S‑adenosyl methionine, phosphate‑restricted diets, benazepril).
- Compare the cost‑effectiveness of treatment options and apply principles to prioritize interventions that maximize patient benefit while minimizing client expense.
- Show that you can develop practical, evidence‑based treatment plans and client communication strategies to implement economically sensible care for chronic kidney and liver disease in veterinary patients.
This session is RACE approved
